Cervical cancer is the fourth most common cancer in women worldwide and is caused by
persistent infection with high‐risk types of human papillomavirus (HPV). HPV viral load, the …

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the
most promising malignancy to be eliminated. However, the ever-changing virus subtypes …

Integration of human papillomavirus (HPV) DNA into the human genome is considered as a
key event in cervical carcinogenesis. Here, we perform comprehensive characterization of …

Human papillomavirus (HPV) integration is a critical step in cervical cancer development;
however, the oncogenic mechanism at the genome-wide transcriptional level is still poorly …

Purpose: Almost all cervical cancers are caused by human papillomavirus (HPV) and
patients with advanced stage are at high risk for relapse. Circulating HPV DNA (HPV ctDNA) …

Integration of high-risk human papillomavirus (HPV) into the host genome is a crucial event
for the development of cervical cancer, however, the underlying mechanism of HPV …

Purpose: Use of circulating tumor DNA (ctDNA) for diagnosis is limited regarding the low
number of target molecules in early-stage tumors. Human papillomavirus (HPV)–associated …

Cervical adenocarcinomas (ADCs), including human papillomavirus (HPV)‐associated
(HPVA) and non‐HPVA (NHPVA), though exhibiting a more malignant phenotype and …

Background Uterine Cervical Carcinoma (UCC) is the most prevalent gynecological
malignancy globally, with a rising incidence in recent years. Accumulating evidence …

Even if a virus successfully binds to a cell, defects in any of the downstream steps of the viral
life cycle can preclude the production of infectious virus particles. Such abortive infections …